Free Trial
NASDAQ:AFCG

AFC Gamma Q2 2025 Earnings Report

AFC Gamma logo
$4.57 +0.05 (+1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$4.54 -0.03 (-0.55%)
As of 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AFC Gamma EPS Results

Actual EPS
N/A
Consensus EPS
$0.24
Beat/Miss
N/A
One Year Ago EPS
N/A

AFC Gamma Revenue Results

Actual Revenue
N/A
Expected Revenue
$8.23 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

AFC Gamma Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
10:00AM ET

Conference Call Resources

AFC Gamma Earnings Headlines

Advanced Flower Capital Inc. (AFCG) - Yahoo Finance
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
AFC Gamma cuts dividend, shares drop most since March
See More AFC Gamma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AFC Gamma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AFC Gamma and other key companies, straight to your email.

About AFC Gamma

AFC Gamma (NASDAQ:AFCG), Inc. is a specialty finance real estate investment trust (REIT) focused on providing capital solutions to the healthcare and life sciences sectors. The company originates, acquires and manages a portfolio of senior secured loans, mezzanine debt and mortgage-related assets secured by healthcare-related real estate and equipment. AFC Gamma’s lending activities are concentrated on ground leases and mortgage loans for medical office buildings, cancer treatment centers, ambulatory surgery centers and other specialized healthcare facilities.

Through its financing platform, AFC Gamma partners with healthcare providers, non-profit organizations and life sciences companies to support facility construction, expansions, refinancings and acquisitions. The company’s investment strategy emphasizes floating-rate debt instruments, which are structured to generate consistent income streams while preserving principal through overcollateralization and borrower equity. By focusing on essential healthcare infrastructure, AFC Gamma aims to align its portfolio with sectors exhibiting stable demand and long-term growth potential.

Since its inception in 2019 and subsequent internalization as a REIT, AFC Gamma has built a diversified loan portfolio across the United States. Headquartered in Irvine, California, the firm leverages a team of professionals with deep experience in healthcare finance, real estate lending and credit risk management. Its flexible balance sheet and capital markets access enable the company to pursue both originating new loan commitments and acquiring performing assets from third parties.

Under the leadership of co-founder and Chief Executive Officer Alfred Gargulak, AFC Gamma has grown its footprint by focusing on niche healthcare lending opportunities that can benefit from tailored financing structures. The company’s management team combines backgrounds in banking, private credit and structured finance, positioning AFC Gamma to respond to evolving market dynamics and borrower needs within the healthcare real estate sector.

View AFC Gamma Profile

More Earnings Resources from MarketBeat